|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Property and equipment, net (Note 3) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred compensation (Note 4) | ||||||||||||||||||||
| Convertible notes payable - affiliates (Note 5) | ||||||||||||||||||||
| Convertible notes payable (Note 5) | ||||||||||||||||||||
| Convertible bridge note payable (Note 5) | ||||||||||||||||||||
| Note payable - related party (Note 5) | ||||||||||||||||||||
| Operating lease liability, current (Note 8) | ||||||||||||||||||||
| Demand note payable | ||||||||||||||||||||
| Demand note payable - related party (Note 5) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liability, long term (Note 8) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Common stock, no par value, 250,000,000 shares authorized, 58,116,620 and 57,386,476 shares issued, respectively; 57,412,311 and 56,682,167 shares outstanding, respectively | ||||||||||||||||||||
| Shares to be issued (Note 8) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Subscription receivable - affiliates (Note 7) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Bion's stockholders’ equity (deficit) | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity (deficit) | ||||||||||||||||||||
| Total liabilities and Equity (deficit) | ||||||||||||||||||||
Loading...